News Releases


On Sept. 20, 2017 Goldbelt C6 has been awarded a 5 year, $20 Million indefinite delivery/indefinite quantity (IDIQ) contract with U.S. Food and Drug Administration (FDA).  Under this contract, we will primarily support the FDA in protecting and advancing the safety and security of all public health related products and services worldwide. This contract award is directly in line with Goldbelt C6’s primary focus to provide scientific services within the Research and Development marketplace. 


Goldbelt C6 is pleased to announce that on February 23rd, 2015, the company was admitted to the SBA 8a program. 


Goldbelt C6 launches its new website!